TY  - JOUR
AU  - Zarzuelo-Romero, María José
AU  - Pérez-Ramírez, Cristina
AU  - Cura, Yasmín
AU  - Carrasco-Campos, María Isabel
AU  - Marangoni-Iglecias, Luciana María
AU  - Ramírez-Tortosa, María Carmen
AU  - Jiménez-Morales, Alberto
PY  - 2021
DO  - 10.3390/jpm11101032
SN  - 2075-4426
UR  - https://hdl.handle.net/10668/26321
T2  - Journal of personalized medicine
AB  - Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of autoimmune origin, in which inflammation and demyelination lead to neurodegeneration and progressive disability. Treatment is aimed at slowing down the course of the disease...
LA  - en
KW  - glatiramer acetate
KW  - medicine personalized
KW  - multiple sclerosis
KW  - myelin basic protein
KW  - pharmacogenetics
KW  - polymorphisms
KW  - response
KW  - treatment
TI  - Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients.
TY  - research article
VL  - 11
ER  -